Vifor Pharma AG (VIFN:SW) (GNHAY) PT Lowered to CHF120 at JPMorgan
Tweet
Share
E-mailGet Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Trade Now!
Join SI Premium – FREE
JPMorgan analyst James Gordon lowered the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF120.00 (from CHF130.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Siemens AG (SIE:GR) (SIEGY) PT Raised to EUR170 at Jefferies
- ESR Cayman Ltd (1821:HK) (ESRCF) PT Raised to HK$29.20 at Morgan Stanley
- United Internet AG (UTDI:GR) PT Raised to EUR36 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
